On October 16, 2025, the 67th (Autumn 2025) National Pharmaceutical Machinery Expo and China International Pharmaceutical Machinery Expo grandly opened at the Qingdao World Expo City. This exhibition brings together more than 1600 exhibitors from 25 countries and regions around the world, working together to create a vision of pharmaceutical equipment innovation in a 150000 square meter exhibition space.

At this critical stage of the completion of the 14th Five Year Plan and the comprehensive implementation of the new pharmacopoeia, facing the urgent needs of improving the quality and efficiency of the pharmaceutical industry and achieving independent and controllable industrial chains, Zhejiang Tailin Biotechnology Co., Ltd. (hereinafter referred to as "Tailin Biotechnology") presented more than 40 independently developed innovative equipment and N+industry solutions in the CE-13 exhibition area under the theme of "Intelligent Leading Aseptic New Environment and Innovative Pharmaceutical Future". With a hard core technology matrix with independent intellectual property rights, it showcased the breakthrough achievements of China's pharmaceutical equipment in digital intelligence integration and compliance upgrading, attracting many professional audiences at home and abroad to stop and exchange ideas.

Recently, the implementation of the 2025 edition of the Chinese Pharmacopoeia and the new GMP sterile appendix has raised higher requirements for quality control in the pharmaceutical industry. At this exhibition, Tailin Biotech products focused on the layout of the "compliance" system and launched multiple instruments and supporting solutions that accurately connect with new regulations, demonstrating their dual advantages in cutting-edge detection technology and regulatory compliance.

In the field of aseptic testing, multiple bacterial collectors can be used with newly upgraded bacterial culture equipment, equipped with various materials such as MCE, N66, PES, PVDF, and PTFE filter membranes, fully meeting the requirements of pharmacopoeia aseptic testing. The microbial limit tester is equipped with multiple filter cups and filters, which meet the requirements of the pharmacopoeia for microbial limit testing.

Tailin Biotechnology has launched a solution that combines a bacterial collection instrument with a membrane filter for difficult filtration samples, and is equipped with sampling consumables such as water bags, homogenizers and homogenizers for preparing test solutions, and validation consumables such as quality control strains. We provide enterprises with a complete quality control solution for raw materials, packaging materials, semi-finished products, and finished products.

As a weak link in aseptic production, glove integrity testing is increasingly required to comply with GMP aseptic appendices both domestically and internationally. The GIT-WLAN03 glove integrity tester, newly upgraded by Tailin Biotech, adopts the concept of "Quality by Design (QbD)" and integrates wireless communication and intelligent software technology. Its detection system strictly follows the industry's ALCOA+principle and can automatically generate electronic test reports that comply with GMP standards.

In terms of data integrity, with the deepening of industry awareness, the new version of the pharmacopoeia further clarifies the compliance requirements for microbiological testing data. Tailin Biological's intelligent microbial detection equipment, such as the SCW series fully automatic colony counting workstation, not only integrates AI algorithms and multimodal detection technology to achieve full process electronic operation, but also is equipped with three-level permission management, electronic signature, and audit tracking functions, fully complying with regulatory requirements and providing technical support for enterprises to establish a reliable data integrity and process traceability system.

In terms of water quality monitoring, the DC200 online total organic carbon (TOC) analyzer adopts ultraviolet oxidation technology, which can accurately detect ultra-low concentration organic compounds with a detection limit of 0.030ppb; The GM200 online total organic carbon (TOC) analyzer is based on the principle of thin film conductivity, using a gas separation membrane to selectively permeate carbon dioxide after organic matter oxidation, effectively avoiding interference from acids, bases, and halides on the test. Both have complete data recording and alarm functions, fully complying with the strict standards of ChP, USP, and GMP for water quality monitoring, becoming a solution for sterile drug production enterprises to improve their water quality control level.

At the exhibition site, there are also many customers from overseas, such as South Korea, Russia, Uzbekistan, Bangladesh, Italy and other countries and regions, who are particularly concerned about the integrity of equipment data.

Xia Xinqun, Vice President of Tailin Biotechnology, stated that the trend of globalization and national policy orientation are driving companies to strengthen their emphasis on compliance upgrades. This is not only to meet the increasingly strict regulations at home and abroad, but also to fulfill the responsibility of high-quality development and ensuring drug safety. We are actively integrating stricter standards into our research and quality system, which is not only the cornerstone of benchmarking international competition, but also to lay a solid foundation for the national pharmaceutical industry in complex environments

In the interweaving of era changes and technological waves, the Chinese pharmaceutical industry is entering a critical window of transformation and upgrading. Tailin Biotechnology is willing to work hand in hand with industry colleagues, taking innovative technology as the boat and compliance quality as the sail, to jointly explore new paths for pharmaceutical intelligent manufacturing and explore new horizons for industrial development.

The 2025 Autumn Qingdao Pharmaceutical Machinery Exhibition is currently in full swing. We sincerely invite you to visit the CE-13 Tailin Biotechnology booth, experience a series of innovative achievements on site, and explore the future trends of pharmaceutical technology with us. Together, we will embark on a new journey of "leading the sterile new environment with intelligence and opening up the future of pharmaceuticals"!